41554 blogs · 4,417,066 posts Claim your blog

Record · corpus.blog/posts/01a0c587-b2dd-73d2-9932-6c8a98a4bdcb

The F.D.A.’s controversial ruling on an Alzheimer’s drug (letter from a reader)(ii)

Error Statistics Philosophy · published 9 June 2021

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at errorstatistics.com Wayback capture

1blogs citing

First cited: 12 Jun 2021
Most recent: 12 Jun 2021
Rank this month: not ranked
Links from this post: 5
Words captured: 3,089

Cited by

Blog

In the post

Date

Whassup with the FDA approval of that Alzheimer’s drug? A “disgraceful decision” or a good idea? Read at the source ↗

12 Jun 2021

Links from this post

Link

Host

https://errorstatistics.com/wp-content/uploads/2021/06/screen-shot-2021-06-08-at-8.30.43-pm.png

errorstatistics.com

https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease

fda.gov

https://hdsr.mitpress.mit.edu/pub/bd5k4gzf/release/3

hdsr.mitpress.mit.edu

https://www.buzzfeednews.com/article/stephaniemlee/alzheimers-aducanumab-biogen-fda-approval

buzzfeednews.com

https://endpts.com/what-does-a-clear-majority-of-the-biopharma-industry-think-of-the-fda-approval-of-aducanumab-horrifying-dangerous-confusing-disaster/

endpts.com